On 20 & 21 March, we organized our 5th TMT credit days with eight issuers in the telecoms, media and technology sectors: ams OSRAM, Cellnex, Ipsos, Masmovil, Nexi, Orange, SoftBank Group and Worldline. 84 credit investors registered to the event. - This document summarizes our feedback of the virtual meetings by issuer. - > - - - ...
On 20 & 21 March, we organized our 5th TMT credit days with eight issuers in the telecoms, media and technology sectors: ams OSRAM, Cellnex, Ipsos, Masmovil, Nexi, Orange, SoftBank Group and Worldline. 84 credit investors registered to the event. - This document summarizes our feedback of the virtual meetings by issuer. - > - - - ...
MILAN--(BUSINESS WIRE)-- Le conseil d'administration de Nexi S.p.A. a approuvé le 6 mars les résultats financiers consolidés du groupe au 31 décembre 2023. « En 2023, nous avons poursuivi notre parcours de croissance dans toutes les zones géographiques, nous avons encore augmenté nos marges et considérablement accéléré la génération de trésorerie. Par ailleurs, nous avons encore progressé dans l’innovation produit, la modernisation de nos plateformes technologiques, le renforcement de nos compétences et l’intégration de notre organisation, ce qui nous permet d’accélérer encore l’efficacité e...
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
>2023 results in line with expectations at the operating level - Nexi just released its 2023 results. operating performances were satisfactory relative to expectations with:organic growth in sales of 7.0% (vs guidance >7%, ODDO BHF = +6.8% and consensus = +6.7% - 2022 = +7.1%). There was an acceleration in Q4 (+6.8%) compared with Q3 (+5.0% - Q2 = +7.3% and Q1 = +9.0%) but on a less demanding base of comparison.EBITDA up 10% pro forma (vs guidance >10%, ODDO...
>Résultats 2023 en ligne avec les attentes au niveau opérationnel - Nexi vient de publier ses résultats 2023. Par rapport aux attentes, les performances opérationnelles s’avèrent satisfaisantes avec :Un CA en croissance organique de 7.0% (vs guidance >7%, ODDO BHF = +6.8% et consensus = +6.7% - rappel 2022 = +7.1%). Une accélération a été constatée au T4 (+6.8%) par rapport au T3 (+5.0% - rappel T2 = +7.3% et T1 = +9.0%) mais à partir d’une base de comparaison pl...
MILANMILAN--(BUSINESS WIRE)-- The Board of Directors of Nexi S.p.A. approved on March 6th the Group’s consolidated financial results as of December 31st 2023. "In 2023, we have continued our growth journey across all geographies, we have further increased our margins, and significantly accelerated cash generation. Additionally, we have made further progress in product innovation, in the modernization of our technological platforms, in the strengthening of our skills, and in the integration of our organization, which allows us to further accelerate efficiency and synergies," commented Paolo B...
>Likelihood of welcome surprises limited for this reporting season - target prices revised down to € 9.5 (vs € 10) for Nexi and € 18 (vs € 20) for Worldline - Ahead of the 2023 earnings publications, we have revised down our EPS forecasts by 2%/5% for Nexi and 5%/6% for Worldline for 2023 and 2024. We understand that household spending was disappointing over the festive period, which is likely to prompt the groups to adopt a cautious stance with regards to the announc...
>Potentiel de bonnes surprises limité sur cette saison de publications – OC révisés en baisse à 9,5 € (vs 10 €) pour Nexi et 18 € (vs 20 €) pour Worldline - En amont des résultats 2023, nous révisons en baisse nos attentes de BPA de 2/5% pour Nexi et 5/6% pour Worldline sur 2023/2024. Nous comprenons que les dépenses des ménages ont été décevantes pendant la période de Noël, ce qui devrait pousser les deux groupes à adopter une position prudente au moment de l’annonce...
Nexi : discussions avec F2i en vue de céder des activités non stratégiques en Italie pour environ 800 m EUR (Bloomberg). Ceconomy : JD.com serait intéressé par une prise de participation. eDreams Odigo : solides résultats au T2 2023/24 grâce au succès de Prime. Alstom : Résultat S1 23/24 et un plan de 2 mds EUR pour protéger le rating IG. >...
Nexi: talks with F2i to sell non strategic assets in Italy for about € 800m (Bloomberg) JD.com said to show interest in Ceconomy stake eDreams Odigo: solid results in Q2 2023/24 thanks to the success of Prime Alstom: H1 23/24 results and € 2bn plan to protect its IG rating>...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.